ZYMERA, INC.

Basic Information

5941 Optical Court
San Jose, CA, 95138-1400

Company Profile

n/a

Additional Details

Field Value
DUNS: 171080885
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 5


  1. Development of a Protease Activity Assay for Melanoma Prognostics

    Amount: $219,564.00

    DESCRIPTION (provided by applicant): The objective of this Phase I project is the development of novel assays for gelatinase - i.e., matrix metalloprotease 2 and 9 - activity using a proprietary enhan ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. IGF::OT::IGF OTHER FUNCTIONS RandD- MEDICAL: BIOMEDICAL (BASIC RESEARCH) SBIR PHASE II TOPIC NO. 266 PROJECT ENTITLED: HOMOGENEOUS NANO PARTICLE- BASED ASSAYS FOR PROTEASE DETECTION

    Amount: $1,103,426.00

    The objectives of the Phase II project are to further develop a new protease detection technology platform with versatile application capabilities (in vitro and in vivo) including cancer applications ...

    SBIR Phase II 2012 Department of Health and Human Services
  3. SBIR Phase II: Bioluminescence Resonance Energy Transfer Probes for Molecular Imaging

    Amount: $600,296.00

    This Small Business Innovation Research (SBIR) Phase II project will demonstrate the production of robust, versatile probes based on Bioluminescence Resonance Energy Transfer to Quantum Dots (BRET-Qdo ...

    SBIR Phase II 2010 National Science Foundation
  4. STTR Phase I: Non-Toxic Nanoparticles for BRET-Based Molecular Imaging

    Amount: $150,000.00

    This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5). This Small Business Technology Transfer (STTR) Phase I project will result in the demonstration of no ...

    STTR Phase I 2009 National Science Foundation
  5. SBIR Phase I: Bioluminescence Resonance Energy Transfer Probes for Molecular Imaging

    Amount: $100,000.00

    This Small Business Innovation Research (SBIR) Phase I project will demonstrate the detection of an established target in cancer diagnosis and treatment using new targeted Bioluminescence Resonance En ...

    SBIR Phase I 2009 National Science Foundation
  6. SBIR Phase I: Bioluminescence Resonance Energy Transfer Assays for Clinical Chemistry

    Amount: $99,993.00

    This Small Business Innovation Research (SBIR) Phase I research project aims to develop a point-of-care assay for creatine kinase, an important toxicity biomarker, to screen for adverse drug reactions ...

    SBIR Phase I 2007 National Science Foundation

Agency Micro-sites

US Flag An Official Website of the United States Government